Percutaneous Nephrolithotomy Market Expansion: Projected to Hit $27.36Billion with 8.8% CAGR by 2029
The percutaneous nephrolithotomy market size is expected to see strong growth in the next few years. It will grow to $27.36 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to growing adoption of minimally invasive surgical procedures, rising demand for effective stone removal techniques, increasing awareness about the benefits of percutaneous nephrolithotomy, growing geriatric population prone to kidney stone formation, growing availability of advanced medical technologies for stone removal, increasing focus on patient-centric care, increasing preference for outpatient procedures. Major trends in the forecast period include adoption of miniaturized instruments, advancement in imaging technologies, implementation of robotics, adoption of disposable devices, advancement in stone retrieval devices, advancement in anesthesia techniques, implementation of enhanced infection control measures, implementation of multimodal pain management, development of training programs.
Get Your Free Sample of The Global Percutaneous Nephrolithotomy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16506&type=smp
How have varous drivers impacted the growth of the percutaneous nephrolithotomy market?
The increasing prevalence of renal diseases is expected to propel the growth of the percutaneous nephrolithotomy market going forward. Renal diseases refer to a range of conditions that affect the kidneys, impairing their ability to function properly. The prevalence of renal diseases is due to rising rates of diabetes and hypertension, an aging population, poor lifestyle choices, genetic predisposition, chronic conditions, and improved awareness and diagnosis. Percutaneous nephrolithotomy helps manage renal diseases by providing a minimally invasive surgical procedure to remove large or complex kidney stones, alleviate pain, prevent urinary tract infections, and improve kidney function. For instance, in June 2023, according to ZS Associates, a UK-based Kidney Research Commission, the prevalence of kidney disease in the UK affected 7.19 million people in 2023 and is expected to rise to 7.61 million by 2033. Therefore, the increasing prevalence of renal diseases is driving the percutaneous nephrolithotomy market.
What are the primary segments of the percutaneous nephrolithotomy market?
The percutaneous nephrolithotomy market covered in this report is segmented –
1) By Type: Magnesium Ammonium Phosphate Stone Type, Calcareous Type, Uric Acid Calculi Type
2) By Component: Accessories, Devices, Services
3) By End-User: Ambulatory Surgical Centers, Clinics, Hospitals
Subsegments:
1) By Magnesium Ammonium Phosphate Stone Type: Struvite Stones, Triple Phosphate Stones
2) By Calcareous Type: Calcium Oxalate Stones, Calcium Phosphate Stones
3) By Uric Acid Calculi Type: Primary Uric Acid Stones, Secondary Uric Acid Stones
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/percutaneous-nephrolithotomy-global-market-report
Which firms are leading the percutaneous nephrolithotomy market?
Major companies operating in the percutaneous nephrolithotomy market are Boston Scientific Corporation, Zimmer Biomet Holdings Inc., Olympus Corporation, Terumo Corporation, Coloplast Corporation, B. Braun, Cook Medical, Teleflex Incorporated, Karl Storz Se And Co. KG, Merit Medical Systems, Richard Wolf GmbH, AngioDynamics, Argon Medical Devices, Dornier MedTech, EDAP TMS, Allengers Medical Systems Limited, DirexGroup, Envaste Limited, ELMED Lithotripsy Systems, PolyDiagnost, Attikouris Enterprises Ltd., Advin Urology, Avenda Health, Guangzhou Potent Optotronic Technology Co. Ltd., Surgimedik
How will industry trends affect the trajectory of the percutaneous nephrolithotomy market?
Major companies operating in the percutaneous nephrolithotomy market are focused on adopting innovative solutions, such as robot-assisted surgical platforms, to enhance surgical precision and patient outcomes. A robot-assisted surgical platform is an advanced medical system that uses robotic technology to assist surgeons in performing complex procedures with greater precision, control, and flexibility. For instance, in February 2023, Ethicon Inc., a US-based Johnson & Johnson MedTech company, reported the successful robotic-assisted removal of kidney stones in the first patient using the MONARCH Platform for urology. It allows urologists to navigate through the kidney using robotic assistance designed for access, clearance, and control using a handheld controller. The platform provides a single platform that supports ureteroscopic and percutaneous nephrolithotomy (PCNL) procedures, offering improved navigation, access, clearance, and control compared to traditional methods.
Which geographic trends are shaping the percutaneous nephrolithotomy market, and which region has the highest market share?
North America was the largest region in the percutaneous nephrolithotomy market in 2024. The regions covered in the percutaneous nephrolithotomy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Percutaneous Nephrolithotomy Market Report 2025 Offer?
The percutaneous nephrolithotomy market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Percutaneous nephrolithotomy (PCNL) is a minimally invasive surgical procedure used to remove kidney stones (renal calculi) from the urinary tract. This procedure involves making a small incision in the skin and creating a direct channel to the kidney through which instruments are inserted to break up and extract the stones. PCNL is employed when other less invasive methods, such as shock wave lithotripsy or ureteroscopy, are ineffective or unsuitable.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16506
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Comments
Post a Comment